1. Evidence for gender differences in electrophysiological properties of canine Purkinje fibres;Abi-Gerges;Br J Pharmacol,2004
2. Anon 2000 Committee for Proprietary Medicinal Products (CPMP). Safety pharmacology studies for human pharmaceuticals. The European Agency for the evaluation of medicinal products
3. Anon 2005a ICH S7B Note for guidance on the nonclinical evaluation of the potential for delayed ventricular repolarization (QT interval prolongation) by human pharmaceuticals
4. Anon 2005b ICH E14 Note for guidance on the clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs
5. Heterogeneity and cardiac arrhythmias: an overview;Antzelevitch;Heart Rhythm,2007